AnalystsKelsey Goodwin
Kelsey Goodwin's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 28%
#1408 out of 5069 analysts
Average Return
+12%
Win Rate
61%11 out of 18
Risk vs Reward
Poor
Good

Kelsey Goodwin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Genelux CorpGNLX
+85.11%$3.09$5.72
2024-10-29 -
2025-10-17
Strong Buy
Cg Oncology IncCGON
+62.21%$25.56$41.46
2025-08-19 -
2025-10-17
Strong Buy
Bicara Therapeutics IncBCAX
+58.56%$11.51$18.25
2025-08-19 -
2025-10-17
Strong Buy
Revolution Medicines IncRVMD
+48.06%$36.54$54.10
2025-08-19 -
2025-10-17
Strong Buy
Arcellx IncACLX
+45.40%$23.48$34.14
2022-10-31 -
2023-10-30
Strong Buy

Kelsey Goodwin Analyst Color

Get additional color on Kelsey Goodwin's coverage of popular stocks

Kelsey Goodwin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Summit Therapeutics IncSMMT
1Hold$21.00+0.05%Initiates Coverage On
2 months ago
Janux Therapeutics IncJANX
1Strong Buy$42.00+56.95%Initiates Coverage On
2 months ago
Revolution Medicines IncRVMD
1Strong Buy$75.00+38.63%Initiates Coverage On
2 months ago
Urogen Pharma LtdURGN
3Strong Buy$36.00+112.39%Initiates Coverage On
2 months ago
Cg Oncology IncCGON
1Strong Buy$55.00+32.66%Initiates Coverage On
2 months ago
Tango Therapeutics IncTNGX
1Strong Buy$11.00+21.82%Initiates Coverage On
2 months ago
Nuvalent IncNUVL
3Strong Buy$112.00+21.05%Initiates Coverage On
2 months ago
Bicara Therapeutics IncBCAX
1Strong Buy$36.00+97.26%Initiates Coverage On
2 months ago
Century Therapeutics IncIPSC
2Strong Buy$5.00+822.51%Maintains
7 months ago
Genelux CorpGNLX
1Strong Buy$8.00+39.86%Initiates Coverage On
a year ago
2seventy Bio IncTSVT
2Strong Buy$26.00N/AMaintains
2 years ago
Arcellx IncACLX
2Strong Buy$58.00N/AMaintains
2 years ago
Legend Biotech CorpLEGN
1HoldN/AN/AInitiates Coverage On
3 years ago
Iovance Biotherapeutics IncIOVA
1HoldN/AN/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.